MSD has been rumoured to be considering a takeover of Viking Therapeutics in order to get a horse in the obesity therapy race ...

This editorial reviews the impact of phytochemicals on metabolic diseases, emphasizing their potential in reducing ...

In a public health breakthrough, U.S. obesity rates have decreased for the first time in more than a decade, with new weight ...

That's why Robert F. Kennedy Jr.'s pledge to “Make America Healthy Again” as he campaigned alongside Donald Trump caught her attention. She liked the questions Kennedy raised about the role of ...

If you’ve ever felt like your weight impacts your emotional well-being, you’re not alone. In fact, 58% of Americans report ...

In children, the meta-analysis of four of seven studies conducted during summer vacations (six interventions) found a small ...

The kids seen by Dolores Mejia around suburban Phoenix have been growing heavier in recent years. Their parents, too, she ...

Obesity is increasingly becoming a cause of death in Korea, with more than 110,000 individuals dying in 2022 after carrying ...

As the New Year approaches, many adults resolve to eat healthier or give the gym another try, but such resolutions are rare ...

Cardiovascular disease (CVD) is a critical public health concern, with risk factors such as high blood pressure, abnormal blood sugar levels, elevated cholesterol, and obesity beginning in childhood.

By licensing a drug from Hansoh, Merck signaled that it isn’t prepared to fully challenge its rivals' dominance in the GLP-1 ...

Key Takeaways, With Data for Maryland FDA approvals vary by drug: There are currently three GLP-1s on the market that the FDA ...